Survival after tachyarrhythmic arrest--what are we waiting for?

Abstract

n engl j med 358;1 www.nejm.org january 3, 2008 77 gues, in effect, that the granting of FDA approval shields any device manufacturer from state tort liability. Congress worked long and hard last year to reform the FDA in its mission to improve the safety of drugs and medical devices. Congressional scrutiny of the FDA raised serious questions about whether… (More)
DOI: 10.1056/NEJMe0707823

Topics

  • Presentations referencing similar topics